Latest endometrial cancer News

Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer
Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive
Prime time: First therapeutic clinical trial of C’Dots underway
Study offers hope of new treatments for endometrial cancer
QIMR Berghofer scientist elected Fellow of Australian Academy of Health and Medical Sciences
Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial
5 things to know about bowel cancer
Four foods you should eat & three you should avoid to prevent cancer
Key gene identified in endometrial cancer could be targeted in future drug trial
$26m funding injection for cardiovascular and cancer research
$13.6 million for reproductive, childhood brain and other cancer clinical trials
Dark shadow of type 2 diabetes
Diabetes dramatically increases dementia risk, doubles chance of some cancers
Researchers discover new method of detecting endometrial cancer
Breastfeeding linked to lower ovarian cancer risk
QIMR Berghofer scientist named Cure Cancer Researcher of year
Study identifies risk factors for endometrial cancer
Molecular roadmap boosts fight against endometrial cancer
New research to investigate link between obesity and endometrial cancer
Provisional application receives approval through first international collaborative review initiative between TGA, FDA and HC
Provisional approval of lenvatinib in combination with pembrolizumab for treatment of advanced endometrial carcinoma